• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

转甲状腺素蛋白淀粉样变性心肌病患者 Tc 标记焦磷酸盐闪烁显像阳性时的心外膜活检敏感性。

Extracardiac Biopsy Sensitivity in Transthyretin Amyloidosis Cardiomyopathy Patients With Positive Tc-Labeled Pyrophosphate Scintigraphy Findings.

机构信息

Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto University.

Department of Diagnostic Radiology, Graduate School of Medical Sciences, Kumamoto University.

出版信息

Circ J. 2022 Jun 24;86(7):1113-1120. doi: 10.1253/circj.CJ-22-0118. Epub 2022 May 21.

DOI:10.1253/circj.CJ-22-0118
PMID:35599006
Abstract

BACKGROUND

The accurate sensitivity of amyloid deposition in extracardiac tissue (subcutaneous tissue and gastrointestinal tract) has not been evaluated in transthyretin amyloidosis cardiomyopathy (ATTR-CM) patients. This study aimed to evaluate the sensitivity of amyloid deposition in obtained endomyocardial and extracardiac biopsies.

METHODS AND RESULTS

This study retrospectively evaluated 175 consecutive ATTR-CM patients (wild-type [ATTRwt]: 134, hereditary [ATTRv]: 41) who had positive findings on Tc-labeled pyrophosphate (Tc-PYP) scintigraphy and underwent tissue biopsy of at least one organ (subcutaneous tissue, gastrointestinal tract, and endomyocardium). Amyloid deposition was observed in the subcutaneous tissue of 57/150 patients (38%), gastrointestinal tract of 80/131 patients (61%), and endomyocardium of 108/109 patients (99%). Compared to patients with ATTRv, ATTRwt had significantly lower sensitivity in subcutaneous tissue (73% vs. 25%, P<0.01) and tended to be lower in the gastrointestinal tract (74% vs. 57%, P=0.08) biopsies. Among 124 patients who underwent both subcutaneous tissue and gastrointestinal tract biopsies, amyloid was detected in at least 1 specimen in 91 (73%) patients. The sensitivity of the combination of extracardiac biopsies was 66% and 94% in ATTRwt-CM and ATTRv-CM, respectively. Multivariate analysis reveals that ATTRv was the only significant predictor of amyloid deposition in the subcutaneous tissue.

CONCLUSIONS

Subcutaneous tissue and gastrointestinal tract biopsy sensitivity are inadequate, especially in patients with ATTRwt; however, the combination of these extracardiac biopsies contributes to increased sensitivity in patients with positive Tc-PYP scintigraphy findings.

摘要

背景

在转甲状腺素蛋白淀粉样变心肌病(ATTR-CM)患者中,尚未评估细胞外组织(皮下组织和胃肠道)中淀粉样沉积的准确敏感性。本研究旨在评估心肌和细胞外活检中淀粉样沉积的敏感性。

方法和结果

本研究回顾性评估了 175 例连续的 ATTR-CM 患者(野生型[ATTRwt]:134 例,遗传性[ATTRv]:41 例),这些患者 Tc 标记焦磷酸盐(Tc-PYP)闪烁显像阳性,并进行了至少一种器官(皮下组织、胃肠道和心肌)的组织活检。在 150 例患者中有 57 例(38%)在皮下组织中观察到淀粉样沉积,在 131 例患者中有 80 例(61%)在胃肠道中观察到淀粉样沉积,在 109 例患者中有 108 例(99%)在心肌中观察到淀粉样沉积。与 ATTRv 患者相比,ATTRwt 患者在皮下组织中的敏感性明显较低(73%比 25%,P<0.01),在胃肠道中的敏感性也较低(74%比 57%,P=0.08)。在 124 例同时进行皮下组织和胃肠道活检的患者中,91 例(73%)患者至少有 1 个标本检测到淀粉样蛋白。ATTRwt-CM 和 ATTRv-CM 患者中外周活检的敏感性分别为 66%和 94%。多变量分析表明,ATTRv 是皮下组织中淀粉样沉积的唯一显著预测因子。

结论

皮下组织和胃肠道活检的敏感性不足,尤其是在 ATTRwt 患者中;然而,这些外周活检的组合可提高 Tc-PYP 闪烁显像阳性患者的敏感性。

相似文献

1
Extracardiac Biopsy Sensitivity in Transthyretin Amyloidosis Cardiomyopathy Patients With Positive Tc-Labeled Pyrophosphate Scintigraphy Findings.转甲状腺素蛋白淀粉样变性心肌病患者 Tc 标记焦磷酸盐闪烁显像阳性时的心外膜活检敏感性。
Circ J. 2022 Jun 24;86(7):1113-1120. doi: 10.1253/circj.CJ-22-0118. Epub 2022 May 21.
2
Non-invasive detection and differentiation of cardiac amyloidosis using Tc-pyrophosphate scintigraphy and C-Pittsburgh compound B PET imaging.使用 Tc-焦磷酸盐闪烁扫描和 C-Pittsburgh 化合物 B PET 成像进行非侵入性心脏淀粉样变性的检测和鉴别。
Amyloid. 2020 Dec;27(4):266-274. doi: 10.1080/13506129.2020.1798223. Epub 2020 Jul 28.
3
A Gluteus Medius Muscle Biopsy to Confirm Amyloid Transthyretin Deposition in Wild-type Transthyretin Cardiac Amyloidosis: A Report of Two Cases.经臀中肌肌活检证实野生型转甲状腺素蛋白心脏淀粉样变性中的转甲状腺素蛋白淀粉样沉积:两例报告。
Intern Med. 2024 Jun 1;63(11):1575-1584. doi: 10.2169/internalmedicine.2742-23. Epub 2023 Oct 27.
4
Performance of Tc-PYP scintigraphy in the diagnosis of hereditary transthyretin cardiac amyloidosis.Tc-PYP 闪烁显像术在遗传性转甲状腺素蛋白心脏淀粉样变性诊断中的应用。
Ann Nucl Med. 2024 Apr;38(4):288-295. doi: 10.1007/s12149-023-01898-x. Epub 2024 Jan 22.
5
Technetium-99m-pyrophosphate imaging-based computed tomography-guided core-needle biopsy of internal oblique muscle in wild-type transthyretin cardiac amyloidosis.基于 99mTc-焦磷酸盐的计算机断层扫描引导下对野生型转甲状腺素蛋白心脏淀粉样变性患者内斜肌进行芯针活检。
Amyloid. 2024 Mar;31(1):12-21. doi: 10.1080/13506129.2023.2235881. Epub 2023 Jul 24.
6
Temporal Trends in Diagnostic Testing Patterns for Wild-Type Transthyretin Amyloid Cardiomyopathy in the Medicare Fee-for-Service Population.医疗保险按服务收费人群中野生型转甲状腺素蛋白淀粉样心肌病诊断检测模式的时间趋势
Am J Cardiol. 2022 Mar 15;167:98-103. doi: 10.1016/j.amjcard.2021.11.048. Epub 2022 Jan 10.
7
Technetium-pyrophosphate scintigraphy: a practical guide for early diagnosis of transthyretin amyloid cardiomyopathy.锝焦磷酸盐闪烁扫描术:转甲状腺素淀粉样变心肌病早期诊断的实用指南。
ESC Heart Fail. 2022 Feb;9(1):251-262. doi: 10.1002/ehf2.13693. Epub 2021 Nov 29.
8
Inverse correlation between age of onset and myocardial amyloid deposition quantified by Tc-PYP scintigraphy in patients with wild-type transthyretin amyloid cardiomyopathy.野生型转甲状腺素蛋白淀粉样心肌病患者通过 Tc-PYP 闪烁显像定量检测发病年龄与心肌淀粉样沉积呈反比关系。
Ann Nucl Med. 2024 Sep;38(9):744-753. doi: 10.1007/s12149-024-01943-3. Epub 2024 Jun 14.
9
Amyloid myopathy: expanding the clinical spectrum of transthyretin amyloidosis-case report and literature review.淀粉样变心肌病:转甲状腺素蛋白淀粉样变性的临床谱扩大——病例报告及文献复习。
J Nucl Cardiol. 2023 Aug;30(4):1420-1426. doi: 10.1007/s12350-022-02990-x. Epub 2022 May 17.
10
Amyloid deposit corresponds to technetium-99m-pyrophosphate accumulation in abdominal fat of patients with transthyretin cardiac amyloidosis.淀粉样蛋白沉积物与转甲状腺素蛋白心脏淀粉样变性患者腹部脂肪中99m锝焦磷酸盐的积聚相对应。
J Nucl Cardiol. 2022 Dec;29(6):3126-3136. doi: 10.1007/s12350-021-02890-6. Epub 2021 Dec 28.

引用本文的文献

1
Echocardiographic findings of patients with transthyretin amyloid cardiomyopathy.转甲状腺素蛋白淀粉样心肌病患者的超声心动图表现
J Echocardiogr. 2025 Mar;23(1):1-9. doi: 10.1007/s12574-024-00672-w. Epub 2024 Dec 27.
2
Case Report: Transthyretin Glu54Leu-a rare mutation with predominant cardiac phenotype.病例报告:转甲状腺素蛋白Glu54Leu——一种以心脏表型为主的罕见突变。
Front Cardiovasc Med. 2023 Oct 31;10:1228410. doi: 10.3389/fcvm.2023.1228410. eCollection 2023.
3
A Gluteus Medius Muscle Biopsy to Confirm Amyloid Transthyretin Deposition in Wild-type Transthyretin Cardiac Amyloidosis: A Report of Two Cases.
经臀中肌肌活检证实野生型转甲状腺素蛋白心脏淀粉样变性中的转甲状腺素蛋白淀粉样沉积:两例报告。
Intern Med. 2024 Jun 1;63(11):1575-1584. doi: 10.2169/internalmedicine.2742-23. Epub 2023 Oct 27.
4
Optimal practices for the management of hereditary transthyretin amyloidosis: real-world experience from Japan, Brazil, and Portugal.遗传性转甲状腺素蛋白淀粉样变性症管理的最佳实践:来自日本、巴西和葡萄牙的真实世界经验。
Orphanet J Rare Dis. 2023 Oct 12;18(1):323. doi: 10.1186/s13023-023-02910-3.
5
Prevalence and Treatment of Arrhythmias in Patients With Transthyretin and Light-Chain Cardiac Amyloidosis.转甲状腺素蛋白和轻链型心脏淀粉样变性患者心律失常的患病率及治疗
Circ Rep. 2023 Jun 23;5(7):298-305. doi: 10.1253/circrep.CR-23-0022. eCollection 2023 Jul 10.